The News Review:

- Hands-nly Resuscitation K for Cardiac Arrest
- ACRN’s ncology-focused Contract Research rganization Exceeds…
- Synchron acquires Parexel’s bio-analytical and bio-marker…
- Gene mutations tied to immune comeback during therapy for HIV-1
- CRI Worldwide Significantly Expands Kirkbride Division

Hands-nly Resuscitation K for Cardiac Arrest
Washington Post – Mar 31, 2008
Abella clinical research director at the University of Pennsylvania Center for Resuscitation Science added “in a case of cardiac stress it’s probably unrealistic for a member of the public to know what 100 pushes a minute and 2 inches of depth are. “So the new guidelines work out to a simple two-step measure: First dial 911 to call for emergency medical help then begin hands-only CPR. “It’s fairly clear that CPR when done by any standard can double or potentially triple survival” Abella said. “That is great enough to warrant any risk. “The hands-only advice also eliminates a potential hindrance to providing help — fear of what might happen with mouth-to-mouth contact Abella said.

ACRN’s ncology-focused Contract Research rganization Exceeds…
Genetic Engineering News – Genetic Engineering News (press release) – Mar 31, 2008
Close working relationships withdemographically diverse US oncology practices result. a privately held company significantly enhances the speedaccuracy and productivity of conducting clinical research in the communityoncology setting. Proactive project management with focused teams of clinicalexperts achieves these goals. Well-defined processes augmented by proprietarytechnology provide oversight and efficiencies on study functions for bothpharma and participating sites. Strong site relationships enable ACRN CR to achieve enrollment targetswithin required timelines. Well-defined processes for site selection includecomprehensive study-specific questionnaires feasibility assessments andexpert evaluation of potential sites ensuring a high probability of successfor each study.

Synchron acquires Parexel’s bio-analytical and bio-marker…
The Cheers – Mar 31, 2008
The positive outcome of this audit reinforces the commitment to quality by all the employees of Synchron. The company also participates in World Wide Quality Assurance program driven by PAREXEL to provide consistent global standards to our clients. Synchron clinical research business has broad based loyal client franchise with repeat business. And with 90 per cent Europe and US clients who will only be further assured with this new facility offering international level clinical research capabilities. Synchron also hopes to look for more opportunities in Europe in future for catering new areas of contract research with Indian synergy. Apart from Europe Synchron has already started operations in other Asian countries first being it’s venture in Thailand… Synchron also hopes to look for more opportunities in Europe in future for catering new areas of contract research with Indian synergy. Apart from Europe Synchron has already started operations in other Asian countries first being it’s venture in Thailand. ” We are looking for more operations in other countries soon to increase our foot-print in Asia” said Dr. (ANI)© 2007 ANI.

Gene mutations tied to immune comeback during therapy for HIV-1
News-Medical.net – Mar 31, 2008
2Department of Medicine The University of Texas Health Science Center at San Antonio. 3Departments of Microbiology & Immunology and Biochemistry UT Health Science Center San Antonio. 4Infectious Disease Clinical Research Program Uniformed Services University Bethesda Md. 5Infectious Diseases Service and 6Henry M. Jackson Foundation Wilford Hall Medical Center (U. Air Force) San Antonio Texas.

CRI Worldwide Significantly Expands Kirkbride Division
Genetic Engineering News – Genetic Engineering News (press release) – Mar 31, 2008
“With its outstanding access to a dense patient populationindustry leading investigators proximity to leading clinical talentand recognized excellence in clinical quality CRI’s KirkbrideDivision is one of our premier research centers” said Ken KingPresident and Chief Executive fficer CRI Worldwide. The transition to the new facility at CRI at Kirkbride Center wascompleted in February 2008. About CRI Worldwide CRI Worldwide Inc. with headquarters in Clementon NJ is aleading provider of clinical development testing and research servicesfor central nervous system psychiatric and other drug compounds. Thecompany conducts Phase I-IV inpatient and outpatient studies in fullylicensed and accredited acute care hospitals. Additional informationis available at www… a leading provider of clinical researchservices to the global pharmaceutical and biotech industry hasannounced a major expansion of its Kirkbride Division. The facility ishoused within the Kirkbride Center an acute care psychiatric hospitallocated in West Philadelphia near the University of Pennsylvania. Thenewly renovated clinical research center nearly quadruples CRI’sprevious space and allows the firm to conduct both inpatient andoutpatient clinical trials from early stage through late stage atone state-of-the-art facility. “The expansion of Kirkbride allows CRI Worldwide to have some ofthe greatest research scientists all working collaboratively under oneroof” said Dr. Howard Hassman Founder and Chief Scientific fficerCRI Worldwide. “The expanded modernized facility provides a superiorenvironment for CRI to perform Phase I-IV clinical trials – bothinpatient and outpatient – and to more effectively meet patientclient and sponsor needs. Kirkbride Center is the first psychiatric hospital in the US.